SCHEMBL26291480

SCHEMBL26291480

C=CC(=O)OCOc1ccc2cc(-c3ccccc3OC)oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.47
▸ AR P10275 1/20 0.44
▸ SRD5A1 P18405 1/20 0.44
▸ SRD5A2 P31213 1/20 0.44
▸ AHR P35869 1/20 0.43
▸ MAOB P27338 2/20 0.43
▸ MAOA P21397 1/20 0.43
▸ KMT2A Q03164 5/20 0.42
▸ MIF P14174 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ HIF1A Q16665 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291539 0.90 PTPN1 (0.58) PTPN1MAOBKMT2AALDH1A1HPGD
SCHEMBL26292249 0.87 ALDH1A1 (0.41) PTPN1SRD5A1SRD5A2KMT2AALDH1A1
SCHEMBL26291461 0.86 RAB9A (0.40) PTPN1MAOBKMT2AALDH1A1HPGD
SCHEMBL26291464 0.83 HDAC6 (0.47) MAOBKMT2AALDH1A1HPGDMEN1
SCHEMBL26291477 0.83 PTPN1 (0.47) PTPN1MAOBALDH1A1HPGDCYP2C19
SCHEMBL23893381 0.81 HIF1A (0.46) PTPN1ARSRD5A1SRD5A2AHR
SCHEMBL26291695 0.81 ALDH1A1 (0.40) PTPN1MAOBKMT2AALDH1A1HPGD
SCHEMBL26292275 0.78 KMT2A (0.40) PTPN1KMT2AALDH1A1CYP3A4MEN1
SCHEMBL7947768 0.78 PTPN1 (0.68) PTPN1ARAHRKMT2AMIF
SCHEMBL18583380 0.78 RAB9A (0.47) KMT2AMIFALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D PTPN1 4651/4885AR 4524/4885SRD5A1 2627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback